Gensia failure spikes biotech's cardiogram.

Extract


Gensia failure spikes biotech's cardiogram.

San Diego's biotechnology industry struggled to recover last week from its worst setback ever: the failure of Protara, Gensia Inc.'s flagship cardiovascular drug, to be effective.

After receiving the pr...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company